Evolus Inc (EOLS)
13.70
+0.46
(+3.47%)
USD |
NASDAQ |
May 16, 16:00
13.70
0.00 (0.00%)
After-Hours: 20:00
Evolus Enterprise Value: 852.64M for May 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 852.64M |
| May 14, 2024 | 823.21M |
| May 13, 2024 | 813.20M |
| May 10, 2024 | 821.96M |
| May 09, 2024 | 845.75M |
| May 08, 2024 | 853.89M |
| May 07, 2024 | 863.91M |
| May 06, 2024 | 862.03M |
| May 03, 2024 | 856.40M |
| May 02, 2024 | 851.17M |
| May 01, 2024 | 813.61M |
| April 30, 2024 | 760.41M |
| April 29, 2024 | 756.65M |
| April 26, 2024 | 739.12M |
| April 25, 2024 | 741.00M |
| April 24, 2024 | 743.51M |
| April 23, 2024 | 756.02M |
| April 22, 2024 | 757.28M |
| April 19, 2024 | 745.38M |
| April 18, 2024 | 747.26M |
| April 17, 2024 | 752.27M |
| April 16, 2024 | 777.93M |
| April 15, 2024 | 767.92M |
| April 12, 2024 | 780.44M |
| April 11, 2024 | 817.99M |
| Date | Value |
|---|---|
| April 10, 2024 | 818.92M |
| April 09, 2024 | 851.30M |
| April 08, 2024 | 851.92M |
| April 05, 2024 | 849.43M |
| April 04, 2024 | 859.40M |
| April 03, 2024 | 869.36M |
| April 02, 2024 | 880.57M |
| April 01, 2024 | 880.26M |
| March 31, 2024 | 895.51M |
| March 28, 2024 | 918.49M |
| March 27, 2024 | 918.49M |
| March 26, 2024 | 909.26M |
| March 25, 2024 | 906.19M |
| March 22, 2024 | 906.80M |
| March 21, 2024 | 905.57M |
| March 20, 2024 | 915.41M |
| March 19, 2024 | 917.26M |
| March 18, 2024 | 918.49M |
| March 15, 2024 | 912.34M |
| March 14, 2024 | 922.79M |
| March 13, 2024 | 920.95M |
| March 12, 2024 | 873.95M |
| March 11, 2024 | 869.31M |
| March 08, 2024 | 872.79M |
| March 07, 2024 | 914.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
80.71M
Minimum
Mar 16 2020
922.79M
Maximum
Mar 14 2024
444.63M
Average
472.46M
Median
Nov 02 2022
Enterprise Value Benchmarks
| Viatris Inc | 29.96B |
| Shockwave Medical Inc | 12.13B |
| Perspective Therapeutics Inc | 913.95M |
| Electromed Inc | 139.24M |
| Xtant Medical Holdings Inc | 119.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.11M |
| Revenue (Quarterly) | 59.33M |
| Total Expenses (Quarterly) | 66.68M |
| EPS Diluted (Quarterly) | -0.22 |
| Gross Profit Margin (Quarterly) | 69.55% |
| Profit Margin (Quarterly) | -22.09% |
| Earnings Yield | -7.59% |
| Normalized Earnings Yield | -7.591 |